Old Web
English
Sign In
Acemap
>
authorDetail
>
Hai Dong Chi
Hai Dong Chi
Eli Lilly and Company
Medicine
Pathology
Taxane
Regimen
Response rate (survey)
2
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study:
2020
Therapeutic Advances in Medical Oncology
Q Zhang
Tao Sun
Yong-mei Yin
Hui ping Li
Min Yan
Zhong Sheng Tong
Christina P. Oppermann
Yunpeng Liu
Rômulo Costa
Man Li
Ying Cheng
Qu Chang Ouyang
Xi Chen
Ning Liao
Xin-hong Wu
Xiao-Jia Wang
Ji-Feng Feng
Roberto Hegg
G B Kanakasetty
Maria A. Coccia-Portugal
Ru Bing Han
Yi Lu
Hai Dong Chi
Ze Fei Jiang
Xi Chun Hu
Show All
Source
Cite
Save
Citations (5)
Consistent efficacy and safety of gemcitabine–paclitaxel in patients with metastatic breast cancer: A retrospective comparison of East Asian and global studies
2014
Asia-pacific Journal of Clinical Oncology
Binghe Xu
Xiao Qing Zhang
Hai Dong Chi
Zhixin Liu
Mitchell Quinlivan
Mauro Orlando
Show All
Source
Cite
Save
Citations (5)
1